AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remer, E. M.
Right arrow Articles by Baker, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remer, E. M.
Right arrow Articles by Baker, M. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Adrenal Mass Evaluation in Patients with Lung Carcinoma

A Cost-Effectiveness Analysis

Erick M. Remer1, Nancy Obuchowski1,2, James D. Ellis1, Thomas W. Rice3, David J. Adelstein4 and Mark E. Baker1

1 Division of Radiology, The Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195-5103.
2 Departments of Biostatistics and Epidemiology, The Cleveland Clinic Foundation, Cleveland, OH 44195-5103.
3 Department of Cardiothoracic Surgery, The Cleveland Clinic Foundation, Cleveland, OH 44195-5103.
4 Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, OH 44195-5103.



View larger version (10K):

[in a new window]
  		Fig. 1. —Decision tree shows different strategies to evaluate adrenal mass and outcomes for strategies. Possible combinations of CT, MR imaging, and biopsy result in different possible therapeutic options and health states. Three dots indicate continuation to subtree in lower right corner of figure, Ad. = adenoma, Met. = metastasis, Ben. = benign.

 


View larger version (17K):

[in a new window]
  		Fig. 2. —Graph shows two-way sensitivity analysis for sensitivity of CT (10 H) and cost of MR imaging. Best strategy at each combination of variables is shown by decision boundary depicted by line. Note that uncertainty in our parameter estimates could affect selection of best strategy.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Roentgen Ray Society.